Patient advocates

We have a limited number of discounted registrations of €370 for this conference for patient advocates affiliated with patient advocacy organisations. 

To apply for a discounted  registration, you must:

• Be employed by or volunteer for a registered non-profit patient advocacy organisation
• Provide a headed letter from the organisation you represent, indicating how your attendance at the conference will further its charitable aims for the benefit of patients
• Please contact us before the registration deadline to apply.

Lay summary of the topic of the conference

Immunotherapies have shown substantial clinical activity for a subset of patients with cancer. Despite these encouraging results, a large fraction of patients does not respond or fully benefit from current immunotherapies. Most tumours need to evade the immune system in order to thrive. The understanding of how cancer escapes the immune system is crucial in order to identify novel therapeutic targets and approaches to expand the population of patients that could benefit from immunotherapies. In this meeting, top scientists in the field will present the latest discoveries related to the interaction of the immune system with tumours and show the new advances in immunotherapy with the aim of discussing how these therapies can improve the lives of patients.